Skip to content

Instantly share code, notes, and snippets.

@ColinW520
Last active December 2, 2015 21:14
Show Gist options
  • Save ColinW520/4f6c0a327851b56b89d3 to your computer and use it in GitHub Desktop.
Save ColinW520/4f6c0a327851b56b89d3 to your computer and use it in GitHub Desktop.
Give To Cure Collapsible Header Example
/* The list name can be anything, just be sure to reference it appropriately with each child element.*/
<div id="faq_list">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div id="faq2">
<h4 class="content-title-secondary clickable collapsible-header">
<a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
</a>
</h4>
</div>
<div aria-labelledby="faq2" class="collapse" id="faq2Collapse" aria-expanded="false" style="height: 0px;">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div class="collapsible-header-content fr-view">
<p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
<p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div id="faq3">
<h4 class="content-title-secondary clickable collapsible-header">
<a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
</a>
</h4>
</div>
<div aria-labelledby="faq3" class="collapse" id="faq3Collapse" aria-expanded="false">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div class="collapsible-header-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
</div>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div id="faq4">
<h4 class="content-title-secondary clickable collapsible-header">
<a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
</a>
</h4>
</div>
<div aria-labelledby="faq4" class="collapse" id="faq4Collapse" aria-expanded="false">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div class="collapsible-header-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
</div>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div id="faq5">
<h4 class="content-title-secondary clickable collapsible-header">
<a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
WHO IS GIVE TO CURE?
</a>
</h4>
</div>
<div aria-labelledby="faq5" class="collapse" id="faq5Collapse" aria-expanded="false">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div class="collapsible-header-content fr-view">
<p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
<p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
<p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
<p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div id="faq1">
<h4 class="content-title-secondary clickable collapsible-header">
<a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
WHY TARGET CLINICAL TRIALS?
</a>
</h4>
</div>
<div aria-labelledby="faq1" class="collapse" id="faq1Collapse" aria-expanded="false">
<div class="row">
<div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
<div class="collapsible-header-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.
<br>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment